23andMe Collapse Sparks Urgent Questions About Data Responsibility
Once a Silicon Valley darling, DNA testing company 23andMe has now gone into administration—leaving behind not just a troubled balance sheet, but a trove of highly sensitive personal data. Millions of customers entrusted the firm with their genetic information, family histories, and health predispositions. Now, the burning question: what happens to that data? The debate has ignited fears over data ownership, consent, and corporate accountability. In the UK, administrators are bound by GDPR, but the worry remains that valuable genetic data could be sold to settle debts, repurposed without consent, or exposed through weak security controls. This situation highlights a deeper issue: data stewardship isn’t just a technical obligation—it’s a moral one. Companies handling sensitive personal data, especially of the [...]